ECC-2019 is now accepting late breaking abstract submissions for the ECC-2019 Conference. Abstract must report high quality and novel clinical case reports or studies relevant to clinical community and should address to reduce the knowledge gap among clinical disciplines. ECC-2019 cordially welcomes high quality submissions (case reports/research studies) in below format and themes:
Unusual Clinical Disorder/Disease Presentation
Latest Therapeutics Developments & Updates
Novel Radiology/Imaging Techniques
New Surgical Techniques & Procedure
Unexpected or Rare Adverse Drug Effects or Interactions
Rare Diseases Presentations and Management
Abstracts will be published in the official journal of the European Society for Translational Medicine: European Journal of Molecular and Clinical Medicine (EJMCM)[/vc_column_text]
CME and CPD Accreditation
Application will be made for CME/CPD points accreditation to:
Faculty of Pharmaceutical Medicine, Royal Colleges of Physicians of the United Kingdom
Austrian Medical Chamber, Austria
Abstract Submission General Guidelines
All abstracts will be peer reviewed on rolling basis and presenting author will be notified once the committee decision is made.
Abstracts must be submitted via online submission system ONLY. Abstracts submitted via email, fax or by post will not be considered.
Please specify preferred presentation format.
Multiple abstracts can be submitted for consideration by one person. But, only one talk per person would be allowed at the congress. Additional accepted abstracts for poster presentation, can be presented by another registered co-authors or by presenting author after paying additional administrative fees.
Please select submission category and theme that best describes your submission.
Abstract text must not exceed 450 words using 12-Regular Times New Roman font. In addition, one table and/or image can be submitted. Please prepare your abstract file in accordance with ECC-2019 Abstract Template
All presenters and co-authors must disclose any commercial interest/financial relationship.
Please proofread your abstract carefully before submission. Congress team will not be responsible for any typographical errors or other mistakes in the abstract.
By submitting an abstract, the presenting author confirms on behalf of all co-authors that all necessary ethical approvals and copyright permissions are obtained and confirms the originality of the work.
No further changes in the abstract will be permitted upon acceptance.
Abstract submitter should specify if they will consider submitting full manuscript to EUSTM official Journal ‘European Journal of Molecular & Clinical Medicine’ (via Journal Website) for peer review process (After peer review process, if manuscript is found suitable for publication, extra publication charges will be applicable).